Anda di halaman 1dari 3

http://www.p3gobservatory.org:8080/catalogue.htm?

studyId=150

Saudi Biobank
GENERAL INFORMATION
Name Last update Principal investigator Mohammed Al Jumah (Dr.) Saudi Biobank 09/11/2013

King Abdulllah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Saudi Arabia

Contact Mohammed Al Jumah (Dr.)

King Abdulllah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Saudi Arabia Email: JumahM@ngha.med.sa

Website http://www.kaimrc.med.sa/Projects/SaudiBiobank/tabid/165/Default.aspx Funding agencies King Abdulaziz City for Science and Technology (KACST) King Abdullah International Medical Research Center (KAIMRC) National Guard Health Affairs (NGHA)

OBJECTIVES
1. To educate the public about advancements that could come from the study of biological materials. 2. To encourage the donation of specimens. 3. To quantify disease incidence in various populations and subpopulations. 4. To enhance understanding of the natural history and risk factors of diseases, including genome-environment interactions. 5. To accelerate the discovery and development of new diagnostics and therapeutics. Research Focus Broad approach with no specific target of interest (study built as an infrastructure for a broad range of unspecified scientific activities/questions). Target specific questions of interest (predefined scientific targets like, cardiovascular diseases, social environment, specific health trajectories etc.) (Health and diseade outcome, health determinants, risk factors and predictors of diseases/conditions)

METHODS
Legend Yes No Unknown

General design Study design Type of participants Supplementary informations Target or final number of participants Target or final number of families Target or final number of DNA Cohort Individuals, Families A family-based prospective study was suggested, with the sample unit being considered the family rather than the subject, when necessary. Finally, we plan to conduct nested case-control studies within the cohort. This will involve sampling of cases as well as controls to understand the biology of adverse outcome or to identify novel markers. 200000

25000 No information available

Participant selection / Characteristics of the population Selection criteria Country of residence Saudi Arabia

Supplementary informations This study will be concerned with two biobanking groups: 1. A prospective family-based study group, with an expected sample of 100,000 people of all ages, comprising about 20,000 to 25,000 families, after adjusting for the drop-outs, to examine these interactions in a range of common late onset diseases. 2. Disease-specific biobanking group, where samples of people affected by certain diseases such as; cancer (10,000), diabetes (10,000), coronary arteries diseases with one or more risk factors (10,000) (DM, hypertension, etc), hepatitis (5000), obesity (5000), bronchial asthma (5000), chronic renal impairment and failure (5000), stroke (5000), other diseases will be determined following discussion in the steering and international advisory committees etc.( around 100,000 cases) will be allocated from the specialized clinics and primary healthcare clinics. Data Sources

Public Population Project in Genomics. For more information contact us at observat... 1

http://www.p3gobservatory.org:8080/catalogue.htm?studyId=150
Cross-sectional Questionnaires to participants/respondents Direct physical measures Biological samples Longitudinal follow-up

Sample management Biological samples Blood Cord blood Saliva Genome-Wide Association (GWA) analyses Plan to proceed to GWA analyses later

Buccal cells Tissues (Biopsy in case of disease specific group that are lift over from clinical use will be banked.) Urine

GOVERNANCE
Legend Yes No

Allow access to data or samples to external researchers Data (questionnaire-derived, measured) Biological samples

STATUS
Current status Phase Preparation phase/Pilot Baseline recruitment / initial data collection Follow-up of participants Current number of participants recruited We are in the pilot study phase. Current number of collected DNA samples -Start 2010 2013 -End 2010 2016 --

--

COMMENT
The following publication was accepted: Mohammed Al-Jumah, Mostafa A. Abolfotouh, Ibrahim B. Alabdulkareem, Hanan H. Balkhy, Majed I. Al-Jeraisy, Abdulrahman F. Al-Swaid, Eman M. Al-Musaaed, Bandar Al-Knawy.Public Attitude towards Biomedical Research at Outpatient Clinics of King Abdulaziz Medical City Riyadh, Saudi Arabia. East Mediterranean Health Journal. (WHO). Accepted for publication, November,2009. http://kaimrc.med.sa/Projects/SaudiBiobank/PublicationsonSaudiBiobanking/tabid/300/Default.aspx

Public Population Project in Genomics. For more information contact us at observat... 2

http://www.p3gobservatory.org:8080/catalogue.htm?studyId=150

Generated on: 12/31/2013 Website: http://www.p3gobservatory.org

2005 Public Population Project in Genomics. All rights reserved.

Public Population Project in Genomics. For more information contact us at observat... 3